Janecka A - Search Results

1

Synthesis of novel morphiceptin analogues modified in position 3 and their binding to mu-opioid receptors in experimental mammary adenocarcinoma.

Janecka A, Fichna J, Wiercioch R, Mirowski M. Janecka A, et al. Bioorg Med Chem. 2003 Sep 1;11(18):3855-60. doi: 10.1016/s0968-0896(03)00448-6. Bioorg Med Chem. 2003. PMID: 12927845

2

New stereocontrolled synthesis and biological evaluation of 5-(1'-hydroxyalkyl)-3-methylidenetetrahydro-2-furanones as potential cytotoxic agents.

Janecki T, Błaszczyk E, Studzian K, Rózalski M, Krajewska U, Janecka A. Janecki T, et al. Among authors: janecka a. J Med Chem. 2002 Feb 28;45(5):1142-5. doi: 10.1021/jm011019v. J Med Chem. 2002. PMID: 11855994

3

Structure-activity relationship, conformation and pharmacology studies of morphiceptin analogues--selective mu-opioid receptor ligands.

Janecka A, Fichna J, Mirowski M, Janecki T. Janecka A, et al. Mini Rev Med Chem. 2002 Dec;2(6):565-72. doi: 10.2174/1389557023405567. Mini Rev Med Chem. 2002. PMID: 12370041 Review.

4

Effect of cerebral ventricles perfusion with morphiceptin and Met-enkephalin on trigemino-hypoglossal reflex in rats.

Zubrzycka M, Fichna J, Janecka A. Zubrzycka M, et al. Among authors: janecka a. J Physiol Pharmacol. 2002 Dec;53(4 Pt 2):741-50. J Physiol Pharmacol. 2002. PMID: 12510860 Free article.

5

Synthesis of target-specific radiolabeled peptides for diagnostic imaging.

Fichna J, Janecka A. Fichna J, et al. Among authors: janecka a. Bioconjug Chem. 2003 Jan-Feb;14(1):3-17. doi: 10.1021/bc025542f. Bioconjug Chem. 2003. PMID: 12526687 Review. No abstract available.

6

Opioid receptors and their ligands.

Janecka A, Fichna J, Janecki T. Janecka A, et al. Curr Top Med Chem. 2004;4(1):1-17. doi: 10.2174/1568026043451618. Curr Top Med Chem. 2004. PMID: 14754373 Review.

7

Uptake of radiolabeled morphiceptin and its analogs by experimental mammary adenocarcinoma: in vitro and in vivo studies.

Mirowski M, Wiercioch R, Janecka A, Balcerczak E, Byszewska E, Birnbaum G, Byzia S, Garnuszek P, Wierzbicki R. Mirowski M, et al. Among authors: janecka a. Nucl Med Biol. 2004 May;31(4):451-7. doi: 10.1016/j.nucmedbio.2003.12.004. Nucl Med Biol. 2004. PMID: 15093815

8

Binding of the new morphiceptin analogs to human MCF-7 breast cancer cells and their effect on growth.

Janecka A, Fichna J, Kosson P, Zalewska-Kaszubska J, Krajewska U, Mirowski M, Rozalski M. Janecka A, et al. Regul Pept. 2004 Aug 15;120(1-3):237-41. doi: 10.1016/j.regpep.2004.03.014. Regul Pept. 2004. PMID: 15177942

9

Opioid peptides in cancer.

Fichna J, Janecka A. Fichna J, et al. Among authors: janecka a. Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):351-66. doi: 10.1023/B:CANC.0000031773.46458.63. Cancer Metastasis Rev. 2004. PMID: 15197335 Review.

10

Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs.

Fichna J, do-Rego JC, Costentin J, Chung NN, Schiller PW, Kosson P, Janecka A. Fichna J, et al. Among authors: janecka a. Biochem Biophys Res Commun. 2004 Jul 23;320(2):531-6. doi: 10.1016/j.bbrc.2004.05.202. Biochem Biophys Res Commun. 2004. PMID: 15219861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters